No insider purchase over the last 90 days. The latest, by FBU Insider, was filed 31 Aug 2025.
Fletcher Building Limited is a Chemicals company. Its directors and officers file their transactions with NZX. Over the twelve months to 23 October 2026, 19 filings were filed, from 5 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Over the last twelve months, not one insider purchase of Fletcher Building Limited stock was filed. Publication is fast: at least half of the trades appear on NZX on the same day. Until a filing is published, the market cannot know about the trade.
Compared with its exchange (113 companies, median 8 filings), a count of 19 filings is above the norm. Looking back to 2017, when coverage begins, insiders filed 18 purchases and 2 sales.
Other companies in the same sector with recent insider buying flagged by our signals: Heidelberg Materials AG and Titan. Source: insider filings from NZX. Past trades are no guide to future returns.
Analysts rate Fletcher Building Limited Hold (neutral), based on 11 analysts. Average price target: NZ$3.69.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended June 2026 · cache
25 of 223 declarations
FBU is a company operating in the chemicals and materials sector. It is listed on the XNZE market.
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 6 filings published between 11 September and 20 October 2026: no open-market purchase or sale filed by an insider. 6 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 23 October 2026 (UTC)